Atrial fibrillation secondary prevention

Conduction
Sinus rhythm	Atrial fibrillation

Atrial fibrillation
The P waves, which represent depolarization of the atria, are irregular or absent during atrial fibrillation.
ICD-10	I48
ICD-9	427.31
DiseasesDB	1065
MedlinePlus	000184
eMedicine	med/184  emerg/46

WikiDoc Resources for Atrial fibrillation secondary prevention
Articles
Most recent articles on Atrial fibrillation secondary prevention Most cited articles on Atrial fibrillation secondary prevention Review articles on Atrial fibrillation secondary prevention Articles on Atrial fibrillation secondary prevention in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Atrial fibrillation secondary prevention Images of Atrial fibrillation secondary prevention Photos of Atrial fibrillation secondary prevention Podcasts & MP3s on Atrial fibrillation secondary prevention Videos on Atrial fibrillation secondary prevention
Evidence Based Medicine
Cochrane Collaboration on Atrial fibrillation secondary prevention Bandolier on Atrial fibrillation secondary prevention TRIP on Atrial fibrillation secondary prevention
Clinical Trials
Ongoing Trials on Atrial fibrillation secondary prevention at Clinical Trials.gov Trial results on Atrial fibrillation secondary prevention Clinical Trials on Atrial fibrillation secondary prevention at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Atrial fibrillation secondary prevention NICE Guidance on Atrial fibrillation secondary prevention NHS PRODIGY Guidance FDA on Atrial fibrillation secondary prevention CDC on Atrial fibrillation secondary prevention
Books
Books on Atrial fibrillation secondary prevention
News
Atrial fibrillation secondary prevention in the news Be alerted to news on Atrial fibrillation secondary prevention News trends on Atrial fibrillation secondary prevention
Commentary
Blogs on Atrial fibrillation secondary prevention
Definitions
Definitions of Atrial fibrillation secondary prevention
Patient Resources / Community
Patient resources on Atrial fibrillation secondary prevention Discussion groups on Atrial fibrillation secondary prevention Patient Handouts on Atrial fibrillation secondary prevention Directions to Hospitals Treating Atrial fibrillation secondary prevention Risk calculators and risk factors for Atrial fibrillation secondary prevention
Healthcare Provider Resources
Symptoms of Atrial fibrillation secondary prevention Causes & Risk Factors for Atrial fibrillation secondary prevention Diagnostic studies for Atrial fibrillation secondary prevention Treatment of Atrial fibrillation secondary prevention
Continuing Medical Education (CME)
CME Programs on Atrial fibrillation secondary prevention
International
Atrial fibrillation secondary prevention en Espanol Atrial fibrillation secondary prevention en Francais
Business
Atrial fibrillation secondary prevention in the Marketplace Patents on Atrial fibrillation secondary prevention
Experimental / Informatics
List of terms related to Atrial fibrillation secondary prevention

Cardiology Network
Discuss Atrial fibrillation secondary prevention further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Synonyms and related keywords: AF, Afib, fib

Risk factors for ischemic stroke or systemic embolization in patient with non valvular atrial fibrillation

Numbers represents relative risks

1. Advanced age (continuous, per decade) 1.4
2. History of hypertension 1.6
3. Heart failure or impaired left ventricular systolic function 1.4
4. Coronary artery disease (CAD) 1.5
5. Diabetes mellitus (DM) 1.7
6. Previous stroke or Transient Ischemic Attack (TIA) 2.5

ACC / AHA Guidelines- Recommendation for Pacing to Prevent Atrial Fibrillation (DO NOT EDIT)

“

Class III 1. Permanent pacing is not indicated for the prevention of AF in patients without any other indication for pacemaker implantation. (Level of Evidence: B)

”

See Also

• The AF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines

Sources

• The ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Further Readings

• Fuster V, Rydén LE, Cannom DS, et al (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation 114 (7): e257-354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781.
• Estes NAM 3rd, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS, McNamara RL, Messer JV, Ritchie JL, Romeo SJW, Waldo AL, Wyse DG. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Performance Measures for Atrial Fibrillation). Circulation 2008; 117:1101–1120

Template:WikiDoc Sources